Mo1699 Denosumab: A Monoclonal Antibody to Receptor Activator of Nuclear Factor-Kappa B Ligand (RANKL) Decreases Experimental Colitis
Azin Khafipour, Jean‐Eric Ghia(University of Manitoba), Nour Eissa(Children's Hospital Research Institute of Manitoba), Çharles N. Bernstein(University of Manitoba), Peris M. Munyaka, Hongxing Wang(Zhoukou Normal University)
Cited by 0
Related Papers
Environmental triggers in IBD: a review of progress and evidence
|Nature Reviews Gastroenterology & Hepatology|2017|931
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
|Inflammatory Bowel Diseases|2009|525
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
|Gastroenterology|2015|413
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
|Gastroenterology|2009|394